Table 1 Demographic, clinical and laboratory characteristics of all groups

Age.years

58.7 ± 17.7*^a.b.c

63.8 ± 16.0

66.13 ± 16.00

0.01

Gender (Male/Female

45/42

54/39

54/38

0.58

Malignancy. n (%)

14 (16.1)

24 (25.8)

18 (19.6)

0.26

CAD n (%)

9 (10.3)

16 (17.4)

23 (25)

0.04

Hypertension. n (%)

26 (30.2)

30 (32.3)

40 (43.5)

0.13

DiabetesMellitus. n (%)

12 (13.8)

16 (17.2)

23 (25)

0.14

SystolicBp (mmHg)

112.1 ± 18.5

113.0 ± 21.7

109.6 ± 23.7

0.56

DiastolicBp (mmHg)

70.4 ± 10.8

69.9 ± 12.2

70.8 ± 14,0

0.96

Heart Rate (bpm)

87.5 ± 21

107.4 ± 115

118.2 ± 145,2

0.20

O2 saturation (%)

87.3 ± 17.3

87.1 ± 8.5

86.8 ± 15.6

0.98

SHOCK index

0.8 ± 0.2

1,0 ± 0.1

1.1 ± 1.3

0.11

WBC

9.5 ± 3.6

10.7 ± 4.7

12.77 ± 6.3

0.0001

Haemoglobin (g/dL)

14.1 ± 15.5

11.7 ± 2.3

12.5 ± 8.9

0.14

TroponinT mg/dL, median (IQR)

0.11(0.17)^a

0.12(0.24)

0.23(0.48)

0.03

Genevascore

8,8 + 12,5

7,8 + 3,5

7,3 + 3,4

0,44

Wellsscore

5,5 + 2,0

5,4 + 2,0

5,2 + 1,6

0,69

RV dilatation (%)

27 (50.9)

30 (68.2)

38 (74.5)

0.04

EF

59.0 ± 7.5

57.7 ± 7.5

58.6 ± 6.1

0.64

PAB

52.6 ± 21.4

57.1 ± 16.3

54.9 ± 18.3

0.45

RVLV ratio

1,03 ± 0,16

1,16 ± 0,20

1,28 ± 0,23

0.001

Death

2 (2.3)

10 (10.8)

24 (26.1)

0.001

Combine endpoint

3 (3,5)^*a

14 (15,1)

25 (27,5)

0,001